Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 1,603,797. Pennsylvania Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Philadelphia clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Philadelphia storefront.
Your Regenerative Medicine Clinic Partner in Philadelphia, PA for clinics & physicians. Compliance support & pricing — contact Hawk Medical.
We do not have a CDC PLACES uninsured rate for Philadelphia. Expect a mix of JL fee-for-service, Advantage, workers’ comp, and cash-pay, and price them as separate tickets. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Population 1,603,797. The useful question is not “do you have a warehouse on our street?” — it is whether receiving, IFUs, and JL documentation are ready before the first application of regenerative medicine clinic.
National Your Regenerative Medicine Clinic Partner notes (how the product actually works)We do not have a CDC PLACES uninsured rate for Philadelphia. Expect a mix of JL fee-for-service, Advantage, workers’ comp, and cash-pay, and price them as separate tickets. A city of 1M+ with 1,603,797 residents will still mix those payers. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Build two utilization policies if you do both cash PRP and Medicare CTPs.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a Philadelphia trial. Local outcomes stay with the treating physician. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Use that rate for inventory math, not for ads.
CDC PLACES has no incorporated-place row we could match for Philadelphia. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
No. Novitas Solutions writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
No. They are B2B distribution pages for licensed providers. Patients in Philadelphia should speak with their clinician, not use a distributor URL as care instructions.
Start with the CDC National Diabetes Statistics Report and America's Health Rankings diabetes measure (BRFSS). Pennsylvania Department of Health is the state public-health home. Those are the citable sources — not this page’s city name in a headline.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in Philadelphia, PA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Philadelphia is JL geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Pennsylvania Part B wound biologics follow this contractor (siblings: DC, DE, MD, NJ). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 1M+, not a count of orthopedic groups.
No Philadelphia storefront. Joe Bradley is an active practice owner. regenerative medicine clinic stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.